<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jai Radhakrishnan, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard J Glassock, MD, MACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Fernando C Fervenza, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Albert Q Lam, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">KIDNEY DISEASE IN INFECTIVE ENDOCARDITIS</span><span class="headingEndMark"> — </span>Patients with infective endocarditis (IE) can develop several forms of kidney disease: a bacterial infection-related immune complex-mediated glomerulonephritis (GN), renal infarction from septic emboli, and renal cortical necrosis [<a href="#rid1">1-3</a>]. In addition, drug-induced acute interstitial nephritis or acute kidney injury from antibiotics such as aminoglycosides can develop as a result of treating the infection. (See  <a class="medical medical_review" href="/z/d/html/7184.html" rel="external">"Renal infarction"</a> and  <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis"</a> and  <a class="medical medical_review" href="/z/d/html/7214.html" rel="external">"Manifestations of and risk factors for aminoglycoside nephrotoxicity"</a>.)</p><p>The frequency of kidney involvement was illustrated in a retrospective study of over 200 consecutive episodes of bacterial endocarditis [<a href="#rid4">4</a>]. Approximately one-third of patients developed acute kidney injury (of any cause), a complication observed most often among older patients and those with <em>Staphylococcus aureus</em> infection. In a separate series of patients with IE-associated GN, acute kidney injury was the most common clinical presentation [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H2"><span class="h2">Clinical features and kidney biopsy findings</span><span class="headingEndMark"> — </span>The most common organism in IE-associated GN is <em>S. aureus</em>, which is seen in 56 percent of cases (see  <a class="medical medical_review" href="/z/d/html/86317.html" rel="external">"Staphylococcus-associated glomerulonephritis in adults"</a>); <em>Streptococcus </em>species are the next most common. Less common organisms include <em>Bartonella henselae</em>, <em>Coxiella burnetii</em>, <em>Cardiobacterium hominis</em>, and <em>Gemella</em>. In 9 percent of patients with IE-associated GN, no organism could be cultured. One-half of affected patients do not have a known risk factor; in the remainder, common comorbidities included cardiac valve disease (30 percent), intravenous drug use (29 percent), hepatitis C (20 percent), and diabetes (18 percent). The cardiac valve infected was tricuspid in 43 percent, mitral in 33 percent, and aortic in 29 percent of patients in the largest series described [<a href="#rid5">5</a>]. There are a few case reports of patients with IE and GN who developed pulmonary hemorrhage, potentially mimicking other systemic diseases such as antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and antiglomerular basement membrane (anti-GBM) autoantibody disease [<a href="#rid6">6,7</a>]. (See  <a class="medical medical_review" href="/z/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p>Positive ANCA testing has been reported in some cases of IE, which may lead to diagnostic confusion [<a href="#rid5">5,8</a>]. Bartonella endocarditis appears to be associated with particularly high rates of ANCA positivity. In a literature review of 54 cases of Bartonella IE-associated glomerulonephritis, 78 percent were ANCA positive by indirect immunofluorescence and/or enzyme-linked immunosorbent assay (ELISA), and 67 percent were positive for proteinase 3 (PR3)-ANCA [<a href="#rid9">9</a>]. The significance of ANCA is unclear. However, in one series, positive ANCA testing may have been associated with a subacute form of IE leading to multiple valve involvement and more frequent kidney function impairment [<a href="#rid10">10</a>].</p><p>Acute kidney injury is the most common clinical presentation (79 percent), and almost all patients have hematuria (97 percent) [<a href="#rid5">5</a>]. Features of the acute nephritic syndrome were seen in a minority (10 percent), as was nephrotic syndrome (6 percent); 53 percent of patients had reduced C3 complement, and 19 percent had reductions in C4 complement, suggesting activation of the alternative complement pathway. ANCA (usually directed at myeloperoxidase or lactoferrin) may be positive in up to one-third of patients [<a href="#rid5">5</a>]; some patients also have a positive rheumatoid factor, and rare patients are positive for anti-GBM autoantibodies.</p><p>In the largest series, crescentic GN was the most common pattern seen on kidney biopsy specimens by light microscopy (53 percent)  (<a class="graphic graphic_picture graphicRef111391" href="/z/d/graphic/111391.html" rel="external">picture 1</a>) [<a href="#rid5">5</a>]. Diffuse proliferative GN was also a common finding (33 percent), and focal proliferative GN and mild mesangial proliferative GN were seen in a few patients. In addition to GN, the majority of patients showed tubular injury (86 percent) and interstitial inflammation (88 percent). By immunofluorescence microscopy, C3 was present in 94 percent of cases, immunoglobulin staining was observed in less than one-third of biopsies, and immunoglobulin A (IgA)-dominant (or codominant with IgG) staining was seen in 17 percent. A significant proportion of biopsies met the criteria for pauci-immune GN by immunofluorescence (44 percent). On electron microscopy, 90 percent of biopsies showed deposits, most commonly in the mesangial area (84 percent), followed by the subendothelial area (45 percent). Only a minority had subepithelial "humps," which are deposits that are classically seen in infection-related GN (14 percent).</p><p>In another series of 78 patients with staphylococcal infection-related GN, there was marked variability in the degree of IgA staining in the kidney biopsy: trace in 25 percent, mild in 19 percent, moderate in 44 percent, and strong in 12 percent of the cases [<a href="#rid11">11</a>]. A pauci-immune pattern of immunofluorescence was seen in 13 percent of patients. Of the 41 patients who were tested for ANCA, nine (22 percent) were positive. Subepithelial humps were observed in only 31 percent of biopsies.</p><p class="headingAnchor" id="H3"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The presence of IE is usually suggested from the history, cardiac examination, and positive blood cultures. The diagnosis of IE is presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2138.html" rel="external">"Prosthetic valve endocarditis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>In patients with IE and acute kidney injury or an abnormal urinalysis, GN is suspected based upon urinary findings. However, GN must be distinguished from other kidney diseases that can occur in the setting of endocarditis:</p><p class="bulletIndent1"><span class="glyph">●</span>Drug-induced interstitial nephritis, usually with a penicillin, cephalosporin, or quinolone, shares many of the clinical findings of acute GN: hematuria (occasionally, but not usually, with red cell casts), mild proteinuria, and kidney function impairment. Pyuria and white cell casts can be seen in both disorders but are typically the major finding in acute interstitial nephritis.</p><p></p><p class="bulletIndent1">The distinction between these disorders can usually be made from the <strong>timing</strong> of the kidney manifestations. Glomerular involvement is typically near or at its peak of severity just before the institution of appropriate antimicrobial therapy. By contrast, acute interstitial nephritis is a later event, generally requiring 10 or more days of drug treatment [<a href="#rid12">12,13</a>]. If present, eosinophilia and eosinophiluria also point toward this disorder. Recurrent fever may be seen and may erroneously suggest failure of antibiotic therapy. (See  <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aminoglycoside-induced acute tubular necrosis also occurs late (after at least five to seven days of therapy) and is associated with different urinary findings from either the GN or interstitial nephritis. The urinalysis can vary from a bland sediment to one showing multiple muddy brown granular casts, renal epithelial cells, and epithelial cell casts. (See  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7214.html" rel="external">"Manifestations of and risk factors for aminoglycoside nephrotoxicity"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Renal emboli, which can occur as late as several months after bacteriologic cure, should be suspected if there is acute, often unilateral flank pain or evidence of other peripheral emboli. The diagnosis can be confirmed by the finding of focal perfusion defects on a radionuclide scan.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Libman-Sacks endocarditis associated with systemic lupus erythematosus (SLE) and lupus nephritis may present with a clinical picture resembling that of infection-related GN. Serologic abnormalities typically associated with SLE (anti-DNA antibodies) and kidney biopsy showing a "full house" staining pattern are suggestive of SLE [<a href="#rid14">14,15</a>]. (See  <a class="medical medical_review" href="/z/d/html/91781.html" rel="external">"Nonbacterial thrombotic endocarditis"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ANCA-associated vasculitis may be misdiagnosed in patients with endocarditis who present with fevers, systemic symptoms such as GN, vasculitic skin lesions, and a positive test for ANCA and may receive inappropriate immunosuppressive therapy [<a href="#rid16">16</a>]. Blood cultures and an echocardiogram should be performed in such patients. Not infrequently, the diagnosis of infection-related GN is established by kidney biopsy, which shows pauci-immune necrotizing and crescentic GN in ANCA-associated vasculitis but immune deposits (C3, IgG, IgM, IgA, C1q) in infection-related GN. (See  <a class="medical medical_review" href="/z/d/html/3060.html" rel="external">"Clinical spectrum of antineutrophil cytoplasmic autoantibodies", section on 'Infections'</a>.) </p><p></p><p class="headingAnchor" id="H4"><span class="h2">Treatment and outcome</span><span class="headingEndMark"> — </span>Treatment of IE-associated GN includes immediate institution of antimicrobial therapy to promptly eradicate the infection [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2149.html" rel="external">"Right-sided native valve infective endocarditis"</a>.)</p><p>However, control of the infection may not be associated with a favorable outcome. In the series of patients reported above, 21 percent of patients died; of the surviving patients, 10 percent progressed to end-stage kidney disease, 37 percent had persistent kidney function impairment, and only 32 percent had complete kidney recovery [<a href="#rid5">5</a>].</p><p>Glucocorticoids alone or in combination with <a class="drug drug_general" data-topicid="9308" href="/z/d/drug information/9308.html" rel="external">cyclophosphamide</a> have been used in several patients with persistent kidney function impairment despite the use of antibiotics [<a href="#rid5">5,18</a>]. However, there is no conclusive evidence that immunosuppressive therapy improves the outcome of IE-associated glomerulonephritis. In one series that included 15 patients treated with both antibiotics and immunosuppression, four of the 15 patients died, one developed end-stage kidney disease, six had permanent kidney function impairment, and four had complete recovery [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H3575444081"><span class="h1">KIDNEY DISEASE WITH INFECTED VENTRICULAR SHUNTS</span><span class="headingEndMark"> — </span>Shunt nephritis may complicate infected ventricular shunts used for the treatment of hydrocephalus. The frequency of shunt nephritis has markedly declined since ventriculoperitoneal shunts have largely replaced ventriculovascular shunts; shunt nephritis with ventriculoperitoneal shunts is rare [<a href="#rid19">19,20</a>]. In patients with infected ventriculoatrial shunts, shunt nephritis was reported to occur in 0.7 to 2 percent of cases [<a href="#rid21">21,22</a>]. The mechanism of kidney injury probably involves persistent antigenemia derived from an infectious agent with subsequent immune complex formation [<a href="#rid23">23</a>]. The presence of immune complexes induces classical pathway complement activation, which in turn mediates direct injury to glomerular cells (via the C5-9 complex) and generates chemotactic peptides (C3a, C5a) that perpetuate local inflammation.</p><p class="headingAnchor" id="H1880432059"><span class="h2">Clinical manifestations and histopathology</span><span class="headingEndMark"> — </span>Shunt nephritis typically occurs within five years of surgery to place the shunt but can occur decades later, and the diagnosis can sometimes be delayed up to several years after the first clinical manifestation [<a href="#rid24">24</a>]. Patients typically show systemic symptoms and signs (eg, recurrent fever, hepatosplenomegaly, vasculitic skin rash, anemia, and cerebral symptoms). Hypertension is common. The spectrum of kidney function impairment may range from normal kidney function to a rapidly progressive glomerulonephritis (GN) picture [<a href="#rid25">25,26</a>].</p><p>Laboratory testing shows hematuria (sometimes, gross hematuria) and proteinuria (occasionally, nephrotic range). Decreased C3 complement levels and positive cryoglobulins, antineutrophil cytoplasmic autoantibodies (ANCA), rheumatoid factor, and antinuclear antibodies are frequent serologic findings. Cultures of blood and cerebrospinal fluid show mainly <em>S. epidermidis</em> (which might be mistaken for a contaminant in blood cultures). Other bacteria include <em>S. aureus</em>, <em>E. coli</em>, <em>Corynebacterium bovis</em>, <em>Corynebacterium xerosis</em>, <em>Pseudomonas aeruginosa</em>, <em>Pseudomonas cepacia</em>, diphtheroids, <em>Listeria monocytogenes</em>, <em>Bacillus subtilis</em>, <em>Bacillus cereus</em>, <em>Serratia</em>, <em>Cutibacterium acnes</em>, <em>Peptococcus</em>, <em>Mycobacterium gordonae</em>, <em>Micrococcus</em>, <em>Moraxella nonliquefaciens</em>, <em>Moraxella bovis</em>, <em>Acinetobacter</em>, alpha-hemolytic <em>Streptococcus</em> species, and the fungus, <em>Fusarium</em>. However, cultures may be negative, especially if antibiotics were prescribed before obtaining the cultures [<a href="#rid22">22,25,26</a>].</p><p>Kidney biopsy patterns by light microscopy include endocapillary proliferation, membranoproliferative changes, and endocapillary and extracapillary proliferation with crescents. Immunofluorescence microscopy demonstrates granular subendothelial and mesangial deposits containing polyclonal immunoglobulins (immunoglobulin M [IgM] and immunoglobulin G [IgG]) and complement (mainly, C3) [<a href="#rid22">22,26</a>].</p><p class="headingAnchor" id="H1917669896"><span class="h2">Evaluation</span><span class="headingEndMark"> — </span>Although rare, the diagnosis of shunt nephritis should be considered in patients with a history of ventriculovascular shunt placement who present with proliferative GN. In some adult patients, a history of ventriculovascular shunt placement may not be forthcoming, because the shunt placement might have occurred during infancy or childhood.</p><p>In addition, systemic symptoms and a positive ANCA in patients with shunt nephritis may suggest ANCA-associated vasculitis [<a href="#rid19">19</a>], and other positive serologies could suggest lupus nephritis or cryoglobulinemic nephritis [<a href="#rid27">27</a>]. The presence of vasculitic skin lesions may be confused with those of immunoglobulin A vasculitis (Henoch-Schönlein purpura).</p><p>Thus, in patients presenting with proliferative GN who have positive blood cultures, it is important to exclude the presence of a ventriculovascular shunt and, if present, obtain cultures of the cerebrospinal fluid. (See  <a class="medical medical_review" href="/z/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p class="headingAnchor" id="H638377151"><span class="h2">Treatment and prognosis</span><span class="headingEndMark"> — </span>Antibiotic treatment of the underlying infection and shunt removal are essential to kidney recovery; delayed removal or lack of removal of the infected shunt, even if appropriate antibiotics are administered, may be associated with progressive kidney function impairment leading to end-stage kidney disease [<a href="#rid26">26</a>]. Although there are limited data on the role of immunosuppression for shunt nephritis, a short course of glucocorticoids has been used after the shunt has been removed and antibiotics have been initiated [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H139433"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney disease in infective endocarditis </strong>–<strong> </strong>Patients with infective endocarditis (IE) can develop a bacterial infection-related immune complex-mediated glomerulonephritis (GN), renal infarction from septic emboli, and renal cortical necrosis. In addition, a drug-induced acute interstitial nephritis or acute kidney injury (AKI) from antibiotics such as aminoglycosides can develop as a result of treating the infection. (See <a class="local">'Kidney disease in infective endocarditis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical features </strong>– AKI is the most common clinical presentation in IE-associated GN, and almost all patients have hematuria. Features of the acute nephritic syndrome or the nephrotic syndrome are seen but are uncommon. More than one-half of patients have reduced C3 complement; reductions in C4 complement are less frequent. Antineutrophil cytoplasmic autoantibodies (ANCA) may be positive in up to one-third of patients. The most common organism in IE-associated GN is <em>S. aureus</em>, which is seen in 56 percent of cases; <em>Streptococcus </em>species are the next most common. (See <a class="local">'Clinical features and kidney biopsy findings'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pathology </strong>– Crescentic GN is the most frequently observed pattern seen on kidney biopsy specimens by light microscopy (53 percent)  (<a class="graphic graphic_picture graphicRef111391" href="/z/d/graphic/111391.html" rel="external">picture 1</a>), followed by diffuse proliferative GN. The majority of patients also have evidence of tubular injury and interstitial inflammation. By immunofluorescence microscopy, C3 is the predominant finding, and immunoglobulin is present in less than one-third of biopsies. Dominant, or codominant, immunoglobulin A (IgA) staining may be seen in up to one-third of patients. On electron microscopy, subepithelial "humps" were seen in only a minority of patients. A significant proportion of biopsies meet criteria for pauci-immune GN. (See <a class="local">'Clinical features and kidney biopsy findings'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis </strong>– The presence of IE is usually suggested from the history, cardiac examination, and positive blood cultures. In patients with IE and AKI or an abnormal urinalysis, GN is suspected based upon urinary findings. However, other kidney diseases can also occur in the setting of endocarditis, and a kidney biopsy establishes the diagnosis. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment </strong>– Treatment of IE-associated GN includes immediate institution of antimicrobial therapy to promptly eradicate the infection. However, a minority of patients have complete kidney recovery. (See <a class="local">'Treatment and outcome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney disease with infected ventriculovascular shunts </strong>– Shunt nephritis may complicate infected ventricular shunts used for the treatment of hydrocephalus. The frequency of shunt nephritis has markedly declined since ventriculoperitoneal shunts have largely replaced ventriculovascular shunts. (See <a class="local">'Kidney disease with infected ventricular shunts'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical features </strong>– Shunt nephritis typically occurs within five years of surgery to place the shunt, and the diagnosis can sometimes be delayed up to several years after the first clinical manifestation. Patients typically show systemic symptoms and signs (eg, recurrent fever, hepatosplenomegaly, vasculitic skin rash, anemia, and cerebral symptoms). Hypertension is common. The spectrum of kidney function impairment may range from normal kidney function to a rapidly progressive GN. (See <a class="local">'Clinical manifestations and histopathology'</a> above.)</p><p></p><p class="bulletIndent2">Laboratory testing shows hematuria (sometimes, gross hematuria) and proteinuria (occasionally, nephrotic range). Decreased C3 complement levels and positive cryoglobulins, antineutrophil cytoplasmic autoantibodies (ANCA), and antinuclear antibodies are frequent serologic findings. Cultures of blood and cerebrospinal fluid show mainly <em>S. epidermidis</em> (which might be mistaken for a contaminant in blood cultures). Kidney biopsy patterns by light microscopy include endocapillary proliferation, membranoproliferative changes, and endocapillary and extracapillary proliferation with crescents. Immunofluorescence microscopy demonstrates granular subendothelial and mesangial deposits containing polyclonal immunoglobulins and complement. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation </strong>– Although rare, the diagnosis of shunt nephritis should be considered in patients with a history of ventriculovascular shunt placement who present with proliferative GN. In some adult patients, this history may not be forthcoming, because the shunt placement might have occurred during infancy or childhood. In patients presenting with proliferative GN who have positive blood cultures, it is important to exclude the presence of a ventriculovascular shunt and, if present, obtain cultures of the cerebrospinal fluid. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment </strong>– Antibiotic treatment of the underlying infection and shunt removal are essential to kidney recovery; delayed removal or lack of removal of the infected shunt, even if appropriate antibiotics are administered, may be associated with progressive kidney function impairment leading to end-stage kidney disease. (See <a class="local">'Treatment and prognosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Neugarten J, Baldwin DS. Glomerulonephritis in bacterial endocarditis. Am J Med 1984; 77:297.</a></li><li><a class="nounderline abstract_t">Majumdar A, Chowdhary S, Ferreira MA, et al. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant 2000; 15:1782.</a></li><li><a class="nounderline abstract_t">Nasr SH, Radhakrishnan J, D'Agati VD. Bacterial infection-related glomerulonephritis in adults. Kidney Int 2013; 83:792.</a></li><li><a class="nounderline abstract_t">Conlon PJ, Jefferies F, Krigman HR, et al. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 1998; 49:96.</a></li><li><a class="nounderline abstract_t">Boils CL, Nasr SH, Walker PD, et al. Update on endocarditis-associated glomerulonephritis. Kidney Int 2015; 87:1241.</a></li><li><a class="nounderline abstract_t">Griffin KA, Schwartz MM, Korbet SM. Pulmonary-renal syndrome of bacterial endocarditis mimicking Goodpasture's syndrome. Am J Kidney Dis 1989; 14:329.</a></li><li><a class="nounderline abstract_t">Wu HC, Wen YK, Chen ML, Fan CS. Pulmonary-renal syndrome in a patient with bacterial endocarditis. J Formos Med Assoc 2005; 104:588.</a></li><li><a class="nounderline abstract_t">Zhang W, Zhang H, Wu D, et al. Antineutrophil cytoplasmic antibody-positive infective endocarditis complicated by acute kidney injury: a case report and literature review. J Int Med Res 2020; 48:300060520963990.</a></li><li><a class="nounderline abstract_t">Vercellone J, Cohen L, Mansuri S, et al. Bartonella Endocarditis Mimicking Crescentic Glomerulonephritis with PR3-ANCA Positivity. Case Rep Nephrol 2018; 2018:9607582.</a></li><li><a class="nounderline abstract_t">Langlois V, Lesourd A, Girszyn N, et al. Antineutrophil Cytoplasmic Antibodies Associated With Infective Endocarditis. Medicine (Baltimore) 2016; 95:e2564.</a></li><li><a class="nounderline abstract_t">Satoskar AA, Suleiman S, Ayoub I, et al. Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort. Clin J Am Soc Nephrol 2017; 12:39.</a></li><li><a class="nounderline abstract_t">Nolan CM, Abernathy RS. Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia. Arch Intern Med 1977; 137:997.</a></li><li><a class="nounderline abstract_t">Neilson EG. Pathogenesis and therapy of interstitial nephritis. Kidney Int 1989; 35:1257.</a></li><li><a class="nounderline abstract_t">Moyssakis I, Tektonidou MG, Vasilliou VA, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007; 120:636.</a></li><li><a class="nounderline abstract_t">Tarter L, Yazdany J, Moyers B, et al. Clinical problem-solving. The heart of the matter. N Engl J Med 2013; 368:944.</a></li><li><a class="nounderline abstract_t">Ai S, Liu J, Ma G, et al. Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge. Ann Med 2022; 54:754.</a></li><li><a class="nounderline abstract_t">Chapter 10: Immunoglobulin A nephropathy. Kidney Int Suppl (2011) 2012; 2:209.</a></li><li><a class="nounderline abstract_t">Koya D, Shibuya K, Kikkawa R, Haneda M. Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report. BMC Nephrol 2004; 5:18.</a></li><li><a class="nounderline abstract_t">Iwata Y, Ohta S, Kawai K, et al. Shunt nephritis with positive titers for ANCA specific for proteinase 3. Am J Kidney Dis 2004; 43:e11.</a></li><li><a class="nounderline abstract_t">Rifkinson-Mann S, Rifkinson N, Leong T. Shunt nephritis. Case report. J Neurosurg 1991; 74:656.</a></li><li><a class="nounderline abstract_t">Narchi H, Taylor R, Azmy AF, et al. Shunt nephritis. J Pediatr Surg 1988; 23:839.</a></li><li><a class="nounderline abstract_t">Kiryluk K, Preddie D, D'Agati VD, Isom R. A young man with Propionibacterium acnes-induced shunt nephritis. Kidney Int 2008; 73:1434.</a></li><li><a class="nounderline abstract_t">Schena FP, Pertosa G, Pastore A, et al. Circulating immune complexes in infected ventriculoatrial and ventriculoperitoneal shunts. J Clin Immunol 1983; 3:173.</a></li><li><a class="nounderline abstract_t">Harland TA, Winston KR, Jovanovich AJ, Johnson RJ. Shunt Nephritis: An Increasingly Unfamiliar Diagnosis. World Neurosurg 2018; 111:346.</a></li><li><a class="nounderline abstract_t">Arze RS, Rashid H, Morley R, et al. Shunt nephritis: report of two cases and review of the literature. Clin Nephrol 1983; 19:48.</a></li><li><a class="nounderline abstract_t">Haffner D, Schindera F, Aschoff A, et al. The clinical spectrum of shunt nephritis. Nephrol Dial Transplant 1997; 12:1143.</a></li><li><a class="nounderline abstract_t">Strife CF, McDonald BM, Ruley EJ, et al. Shunt nephritis: the nature of the serum cryoglobulins and their relation to the complement profile. J Pediatr 1976; 88:403.</a></li></ol></div><div id="topicVersionRevision">Topic 3054 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6380288" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Glomerulonephritis in bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11071965" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Renal pathological findings in infective endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23302723" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Bacterial infection-related glomerulonephritis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9524779" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Predictors of prognosis and risk of acute renal failure in bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25607109" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Update on endocarditis-associated glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2801704" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pulmonary-renal syndrome of bacterial endocarditis mimicking Goodpasture's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16193181" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pulmonary-renal syndrome in a patient with bacterial endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33078666" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Antineutrophil cytoplasmic antibody-positive infective endocarditis complicated by acute kidney injury: a case report and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30210883" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bartonella Endocarditis Mimicking Crescentic Glomerulonephritis with PR3-ANCA Positivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26817911" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Antineutrophil Cytoplasmic Antibodies Associated With Infective Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27821389" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/879956" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2770107" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pathogenesis and therapy of interstitial nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17602939" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23465105" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Clinical problem-solving. The heart of the matter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35243934" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25018935" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Chapter 10: Immunoglobulin A nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15610562" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15112193" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Shunt nephritis with positive titers for ANCA specific for proteinase 3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2002382" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Shunt nephritis. Case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3183897" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Shunt nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18322539" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A young man with Propionibacterium acnes-induced shunt nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6853685" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Circulating immune complexes in infected ventriculoatrial and ventriculoperitoneal shunts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29325951" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Shunt Nephritis: An Increasingly Unfamiliar Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6831779" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Shunt nephritis: report of two cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9198042" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The clinical spectrum of shunt nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1245951" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Shunt nephritis: the nature of the serum cryoglobulins and their relation to the complement profile.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
